Effect of Vaccine Inoculum on Rotarix Immunogenicity in Bangladesh

Phase 4, randomised, double-blind trial of human rotavirus RIX4414 strain vaccine in rotavirus infection (2 arms), sponsored by The University of Vermont. Primary endpoints: Number (or Percentage) of Infants in Each Study Arm Who Test Positive for Fecal Rotavirus Vaccine-strain Virus Shedding Post-vaccination at 12 weeks, Number (or Percentage) of Infants in Each Study Arm With Rotavirus-specific Plasma Immunoglobulin A (IgA) Seroconversion Post-vaccination at 14 weeks and 1 more. Started Jun 2017; status: completed.